logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Kojie Pharmaceutical-B (02171.HK) spent HK$2.9744 million on November 20 to repurchase 168,000 shares.

date
20/11/2025
Smart Finance News App, Keji Pharmaceutical-B (02171.HK) announced that on November 20, 2025, it will spend 2.9744 million Hong Kong dollars to repurchase 168,000 shares.
Latest
3 m ago
Federal Reserve Chair Jerome Powell: Previously expected the job market to cool down, and the data is confirming this.
4 m ago
AMD and Cisco establish a joint venture for artificial intelligence in Saudi Arabia.
5 m ago
Putin: Russia should master a full set of autonomous technologies in the field of generative artificial intelligence.
5 m ago
Federal Reserve Chair Hammack: Due to inflation issues, it is necessary to maintain some level of restrictiveness in monetary policy.
5 m ago
Federal Reserve Harker: The Federal Reserve must strike a balance between its dual mandate.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.